Review



polyclonal rabbit anti cdkn2a  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech polyclonal rabbit anti cdkn2a
    Polyclonal Rabbit Anti Cdkn2a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 653 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti cdkn2a/product/Proteintech
    Average 96 stars, based on 653 article reviews
    polyclonal rabbit anti cdkn2a - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    94
    Bioss rabbit anti p16
    Effect of ErbB4 receptor agonist and melatonin can ameliorate D-gal-induced aging in hippocampus in mice. (A) Western blot analysis of Lamin B1, p53, p21, <t>p16,</t> GFAP, and Iba-1 protein expression levels in the hippocampus of mice. (B–G) Quantification of Lamin B1, p53, p21, p16, GFAP, and Iba-1 protein levels. Data are presented as mean ± SD, with n = 4–5. *p < 0.05, **p < 0.01, ***p < 0.001.
    Rabbit Anti P16, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p16/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit anti p16 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    Novus Biologicals rabbit polyclonal anti p14 arf
    A NPM1 structural features, including the secondary structure calculated from the oligomerization domain (OD) PDB 4N8M and the nucleic acid binding domain (NBD) PDB 2LLH , using DSSP (2 o Struc.; β-strands are indicated with arrows and α-helicies are indicated with cylinders). The CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.) are shown for the IDR. B <t>p14</t> ARF structural features, including PSI-PRED secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR), and linear hydropathy (Hydro.). The amino acid sequence conservation (Cons.) is based on a multiple sequence alignment using MUSCLE. The bottom panel shows the Rosetta steric zipper propensity energy (R. Energy) calculated using ZipperDB. C CV-SANS curves for p14 ARF -NPM1 condensates, in 100% D 2 O buffer for full scattering intensity (NPM1 and p14 ARF detected; gray trace), in 45% D 2 O buffer where p14 ARF is contrast matched ([ 2 H]-NPM1 detected; green trace), and in 85% D 2 O buffer where [ 2 H]-NPM1 is contrast matched (p14 ARF detected; blue trace). Correlation peaks at ~200 Å and ~400 Å correspond to meso-scale organization of p14 ARF . All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. D Schematic describing NPM1 with extended IDR conformations. E Schematic describing the spatial organization of p14 ARF within p14 ARF -NPM1 condensates. F 2D CC-DARR spectrum of [ 13 C, 15 N]-p14 ARF within the condensed phase. Select resonance assignments are labeled. G Secondary 13 C chemical shifts for [ 13 C, 15 N]-p14 ARF within the condensed phase. Assigned residues are highlighted in gray. The secondary structure prediction from panel B is shown for reference (2 o Struc.; top).
    Rabbit Polyclonal Anti P14 Arf, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti p14 arf/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti p14 arf - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    91
    Boster Bio rabbit anti p16 polyclonal antibody proteintec h
    A NPM1 structural features, including the secondary structure calculated from the oligomerization domain (OD) PDB 4N8M and the nucleic acid binding domain (NBD) PDB 2LLH , using DSSP (2 o Struc.; β-strands are indicated with arrows and α-helicies are indicated with cylinders). The CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.) are shown for the IDR. B <t>p14</t> ARF structural features, including PSI-PRED secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR), and linear hydropathy (Hydro.). The amino acid sequence conservation (Cons.) is based on a multiple sequence alignment using MUSCLE. The bottom panel shows the Rosetta steric zipper propensity energy (R. Energy) calculated using ZipperDB. C CV-SANS curves for p14 ARF -NPM1 condensates, in 100% D 2 O buffer for full scattering intensity (NPM1 and p14 ARF detected; gray trace), in 45% D 2 O buffer where p14 ARF is contrast matched ([ 2 H]-NPM1 detected; green trace), and in 85% D 2 O buffer where [ 2 H]-NPM1 is contrast matched (p14 ARF detected; blue trace). Correlation peaks at ~200 Å and ~400 Å correspond to meso-scale organization of p14 ARF . All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. D Schematic describing NPM1 with extended IDR conformations. E Schematic describing the spatial organization of p14 ARF within p14 ARF -NPM1 condensates. F 2D CC-DARR spectrum of [ 13 C, 15 N]-p14 ARF within the condensed phase. Select resonance assignments are labeled. G Secondary 13 C chemical shifts for [ 13 C, 15 N]-p14 ARF within the condensed phase. Assigned residues are highlighted in gray. The secondary structure prediction from panel B is shown for reference (2 o Struc.; top).
    Rabbit Anti P16 Polyclonal Antibody Proteintec H, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p16 polyclonal antibody proteintec h/product/Boster Bio
    Average 91 stars, based on 1 article reviews
    rabbit anti p16 polyclonal antibody proteintec h - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    p16  (Cusabio)
    93
    Cusabio p16
    A NPM1 structural features, including the secondary structure calculated from the oligomerization domain (OD) PDB 4N8M and the nucleic acid binding domain (NBD) PDB 2LLH , using DSSP (2 o Struc.; β-strands are indicated with arrows and α-helicies are indicated with cylinders). The CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.) are shown for the IDR. B <t>p14</t> ARF structural features, including PSI-PRED secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR), and linear hydropathy (Hydro.). The amino acid sequence conservation (Cons.) is based on a multiple sequence alignment using MUSCLE. The bottom panel shows the Rosetta steric zipper propensity energy (R. Energy) calculated using ZipperDB. C CV-SANS curves for p14 ARF -NPM1 condensates, in 100% D 2 O buffer for full scattering intensity (NPM1 and p14 ARF detected; gray trace), in 45% D 2 O buffer where p14 ARF is contrast matched ([ 2 H]-NPM1 detected; green trace), and in 85% D 2 O buffer where [ 2 H]-NPM1 is contrast matched (p14 ARF detected; blue trace). Correlation peaks at ~200 Å and ~400 Å correspond to meso-scale organization of p14 ARF . All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. D Schematic describing NPM1 with extended IDR conformations. E Schematic describing the spatial organization of p14 ARF within p14 ARF -NPM1 condensates. F 2D CC-DARR spectrum of [ 13 C, 15 N]-p14 ARF within the condensed phase. Select resonance assignments are labeled. G Secondary 13 C chemical shifts for [ 13 C, 15 N]-p14 ARF within the condensed phase. Assigned residues are highlighted in gray. The secondary structure prediction from panel B is shown for reference (2 o Struc.; top).
    P16, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p16/product/Cusabio
    Average 93 stars, based on 1 article reviews
    p16 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    96
    Proteintech polyclonal rabbit anti cdkn2a
    A NPM1 structural features, including the secondary structure calculated from the oligomerization domain (OD) PDB 4N8M and the nucleic acid binding domain (NBD) PDB 2LLH , using DSSP (2 o Struc.; β-strands are indicated with arrows and α-helicies are indicated with cylinders). The CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.) are shown for the IDR. B <t>p14</t> ARF structural features, including PSI-PRED secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR), and linear hydropathy (Hydro.). The amino acid sequence conservation (Cons.) is based on a multiple sequence alignment using MUSCLE. The bottom panel shows the Rosetta steric zipper propensity energy (R. Energy) calculated using ZipperDB. C CV-SANS curves for p14 ARF -NPM1 condensates, in 100% D 2 O buffer for full scattering intensity (NPM1 and p14 ARF detected; gray trace), in 45% D 2 O buffer where p14 ARF is contrast matched ([ 2 H]-NPM1 detected; green trace), and in 85% D 2 O buffer where [ 2 H]-NPM1 is contrast matched (p14 ARF detected; blue trace). Correlation peaks at ~200 Å and ~400 Å correspond to meso-scale organization of p14 ARF . All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. D Schematic describing NPM1 with extended IDR conformations. E Schematic describing the spatial organization of p14 ARF within p14 ARF -NPM1 condensates. F 2D CC-DARR spectrum of [ 13 C, 15 N]-p14 ARF within the condensed phase. Select resonance assignments are labeled. G Secondary 13 C chemical shifts for [ 13 C, 15 N]-p14 ARF within the condensed phase. Assigned residues are highlighted in gray. The secondary structure prediction from panel B is shown for reference (2 o Struc.; top).
    Polyclonal Rabbit Anti Cdkn2a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti cdkn2a/product/Proteintech
    Average 96 stars, based on 1 article reviews
    polyclonal rabbit anti cdkn2a - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    Effect of ErbB4 receptor agonist and melatonin can ameliorate D-gal-induced aging in hippocampus in mice. (A) Western blot analysis of Lamin B1, p53, p21, p16, GFAP, and Iba-1 protein expression levels in the hippocampus of mice. (B–G) Quantification of Lamin B1, p53, p21, p16, GFAP, and Iba-1 protein levels. Data are presented as mean ± SD, with n = 4–5. *p < 0.05, **p < 0.01, ***p < 0.001.

    Journal: Frontiers in Pharmacology

    Article Title: Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway

    doi: 10.3389/fphar.2025.1528604

    Figure Lengend Snippet: Effect of ErbB4 receptor agonist and melatonin can ameliorate D-gal-induced aging in hippocampus in mice. (A) Western blot analysis of Lamin B1, p53, p21, p16, GFAP, and Iba-1 protein expression levels in the hippocampus of mice. (B–G) Quantification of Lamin B1, p53, p21, p16, GFAP, and Iba-1 protein levels. Data are presented as mean ± SD, with n = 4–5. *p < 0.05, **p < 0.01, ***p < 0.001.

    Article Snippet: The antibodies used, diluted in primary antibody diluents (P0023A, Beyotime), included: rabbit anti-phospho-ErbB4 (bs-3220R, Bioss; 1:1,000), rabbit anti-ErbB4 (AF6807, Beyotime; 1:1,000), rabbit anti-phospho-Akt1 (AF1546, Beyotime; 1:1,000), mouse anti-Akt1 (sc-377457, Santa Cruz Biotech; 1:1,000), rabbit anti-Nrf2 (AF7623, Beyotime; 1:1,000), rabbit anti-TFRC (AF8136, Beyotime; 1:1,000), rabbit anti-SLC7A11 (GB115276, Servicebio Biotech; 1:1,000), rabbit anti-GPX4 (AF7020, Beyotime; 1:1,000), rabbit anti-Lamin B1 (12987-1-AP, Proteintech, 1:5,000), rabbit anti-p53 (AF5258, Beyotime; 1:1,000), mouse anti-p21 (AP021, Beyotime; 1:1,000), rabbit anti-p16 (bs-23797R, Bioss Biotech, Beijing, China; 1:1,000), and rabbit anti-GAPDH (GB15002, Servicebio Biotech; 1:2000).

    Techniques: Western Blot, Expressing

    The mitigation of D-gal-induced ferroptosis in HT22 cells by ErbB4 receptor agonist and melatonin. (A) Cell viability post D-gal exposure, evaluated using the CCK-8 assay (n = 5). (B) Cell viability following co-treatment with D-gal and ErbB4 receptor agonist, assessed via the CCK-8 assay (n = 6). (C) Cell viability following co-treatment with D-gal and melatonin, determined by the CCK-8 assay (n = 6). (D) Visualization of cellular senescence through SA-β-gal staining. Scale bar = 100 μm. (E) Quantification of SA-β-gal staining intensities (n = 3). (F) Western blot analysis was conducted to assess the expression levels of senescence-associated markers and ferroptosis-related proteins in HT22 cells. (G–M) Quantification of Nrf2, TFRC, SLC7A11, GPX4, p53, p21, and p16 levels was performed, with normalization to GAPDH (n = 4–7). (N) Intracellular GSH levels (n = 4). (O) Intracellular MDA levels (n = 5). (P) Quantitative analysis of ROS levels was undertaken (n = 4). (Q) Intracellular ROS generation was measured using DCFH-DA, wherein ROS activity was reflected as green fluorescence intensity. Scale bar = 200 μm. Data are presented as mean ± SD. Statistical significance is indicated as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Journal: Frontiers in Pharmacology

    Article Title: Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway

    doi: 10.3389/fphar.2025.1528604

    Figure Lengend Snippet: The mitigation of D-gal-induced ferroptosis in HT22 cells by ErbB4 receptor agonist and melatonin. (A) Cell viability post D-gal exposure, evaluated using the CCK-8 assay (n = 5). (B) Cell viability following co-treatment with D-gal and ErbB4 receptor agonist, assessed via the CCK-8 assay (n = 6). (C) Cell viability following co-treatment with D-gal and melatonin, determined by the CCK-8 assay (n = 6). (D) Visualization of cellular senescence through SA-β-gal staining. Scale bar = 100 μm. (E) Quantification of SA-β-gal staining intensities (n = 3). (F) Western blot analysis was conducted to assess the expression levels of senescence-associated markers and ferroptosis-related proteins in HT22 cells. (G–M) Quantification of Nrf2, TFRC, SLC7A11, GPX4, p53, p21, and p16 levels was performed, with normalization to GAPDH (n = 4–7). (N) Intracellular GSH levels (n = 4). (O) Intracellular MDA levels (n = 5). (P) Quantitative analysis of ROS levels was undertaken (n = 4). (Q) Intracellular ROS generation was measured using DCFH-DA, wherein ROS activity was reflected as green fluorescence intensity. Scale bar = 200 μm. Data are presented as mean ± SD. Statistical significance is indicated as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Article Snippet: The antibodies used, diluted in primary antibody diluents (P0023A, Beyotime), included: rabbit anti-phospho-ErbB4 (bs-3220R, Bioss; 1:1,000), rabbit anti-ErbB4 (AF6807, Beyotime; 1:1,000), rabbit anti-phospho-Akt1 (AF1546, Beyotime; 1:1,000), mouse anti-Akt1 (sc-377457, Santa Cruz Biotech; 1:1,000), rabbit anti-Nrf2 (AF7623, Beyotime; 1:1,000), rabbit anti-TFRC (AF8136, Beyotime; 1:1,000), rabbit anti-SLC7A11 (GB115276, Servicebio Biotech; 1:1,000), rabbit anti-GPX4 (AF7020, Beyotime; 1:1,000), rabbit anti-Lamin B1 (12987-1-AP, Proteintech, 1:5,000), rabbit anti-p53 (AF5258, Beyotime; 1:1,000), mouse anti-p21 (AP021, Beyotime; 1:1,000), rabbit anti-p16 (bs-23797R, Bioss Biotech, Beijing, China; 1:1,000), and rabbit anti-GAPDH (GB15002, Servicebio Biotech; 1:2000).

    Techniques: CCK-8 Assay, Staining, Western Blot, Expressing, Activity Assay, Fluorescence

    The effects of ErbB4 receptor agonist and melatonin treatment on ferroptosis in Erastin-exposed HT22 cells. (A) Cell viability of HT22 cells post-Erastin exposure was evaluated using the CCK-8 assay (n = 5). (B) Cell viability was evaluated following treatment with Erastin, cotreatment with either E4A or melatonin, or both, utilizing the CCK-8 assay (n = 4). (C) Western blot analysis was conducted to determine the expression levels of senescence-associated markers and ferroptosis-related proteins in HT22 cells. (D–I) Quantitative analysis of Nrf2, TFRC, SLC7A11, GPX4, p21, and p16 levels, normalized to GAPDH (n = 4–7). (J) Intracellular ROS generation was measured using DCFH-DA, with ROS activity indicated by green fluorescence. Scale bar = 200 μm. (K) The quantitative analysis of ROS levels was conducted (n = 4). The data are presented as mean ± SD. Statistical significance is indicated as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Journal: Frontiers in Pharmacology

    Article Title: Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway

    doi: 10.3389/fphar.2025.1528604

    Figure Lengend Snippet: The effects of ErbB4 receptor agonist and melatonin treatment on ferroptosis in Erastin-exposed HT22 cells. (A) Cell viability of HT22 cells post-Erastin exposure was evaluated using the CCK-8 assay (n = 5). (B) Cell viability was evaluated following treatment with Erastin, cotreatment with either E4A or melatonin, or both, utilizing the CCK-8 assay (n = 4). (C) Western blot analysis was conducted to determine the expression levels of senescence-associated markers and ferroptosis-related proteins in HT22 cells. (D–I) Quantitative analysis of Nrf2, TFRC, SLC7A11, GPX4, p21, and p16 levels, normalized to GAPDH (n = 4–7). (J) Intracellular ROS generation was measured using DCFH-DA, with ROS activity indicated by green fluorescence. Scale bar = 200 μm. (K) The quantitative analysis of ROS levels was conducted (n = 4). The data are presented as mean ± SD. Statistical significance is indicated as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Article Snippet: The antibodies used, diluted in primary antibody diluents (P0023A, Beyotime), included: rabbit anti-phospho-ErbB4 (bs-3220R, Bioss; 1:1,000), rabbit anti-ErbB4 (AF6807, Beyotime; 1:1,000), rabbit anti-phospho-Akt1 (AF1546, Beyotime; 1:1,000), mouse anti-Akt1 (sc-377457, Santa Cruz Biotech; 1:1,000), rabbit anti-Nrf2 (AF7623, Beyotime; 1:1,000), rabbit anti-TFRC (AF8136, Beyotime; 1:1,000), rabbit anti-SLC7A11 (GB115276, Servicebio Biotech; 1:1,000), rabbit anti-GPX4 (AF7020, Beyotime; 1:1,000), rabbit anti-Lamin B1 (12987-1-AP, Proteintech, 1:5,000), rabbit anti-p53 (AF5258, Beyotime; 1:1,000), mouse anti-p21 (AP021, Beyotime; 1:1,000), rabbit anti-p16 (bs-23797R, Bioss Biotech, Beijing, China; 1:1,000), and rabbit anti-GAPDH (GB15002, Servicebio Biotech; 1:2000).

    Techniques: CCK-8 Assay, Western Blot, Expressing, Activity Assay, Fluorescence

    Schematic diagram illustrating the effects of targeted activation of ErbB4 receptor on neuronal aging via ferroptosis inhibition. Small molecule agonist (E4A)can activate ErbB4 receptors and regulate the Akt/Nrf2 signaling pathway to achieve neuroprotective effect in D-gal-induced neuronal aging. D-gal treatment increases the accumulation of advanced glycation end products (AGEs) which stimulates the production of reactive oxygen species (ROS) and increase the expression of senescence marker genes P53, P16, and P21. E4A can promote Akt1 phosphorylation and promote Nrf2 entrance into the nucleus, in which it involves in regulating the expression of ferroptosis suppressor gene, such as SLC7A11 and GPX4 to attenuate lipid peroxidation, which can inhibit cell ferroptosis and neuronal aging. The diagram was created with MedPeer ( www.medpeer.cn ).

    Journal: Frontiers in Pharmacology

    Article Title: Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway

    doi: 10.3389/fphar.2025.1528604

    Figure Lengend Snippet: Schematic diagram illustrating the effects of targeted activation of ErbB4 receptor on neuronal aging via ferroptosis inhibition. Small molecule agonist (E4A)can activate ErbB4 receptors and regulate the Akt/Nrf2 signaling pathway to achieve neuroprotective effect in D-gal-induced neuronal aging. D-gal treatment increases the accumulation of advanced glycation end products (AGEs) which stimulates the production of reactive oxygen species (ROS) and increase the expression of senescence marker genes P53, P16, and P21. E4A can promote Akt1 phosphorylation and promote Nrf2 entrance into the nucleus, in which it involves in regulating the expression of ferroptosis suppressor gene, such as SLC7A11 and GPX4 to attenuate lipid peroxidation, which can inhibit cell ferroptosis and neuronal aging. The diagram was created with MedPeer ( www.medpeer.cn ).

    Article Snippet: The antibodies used, diluted in primary antibody diluents (P0023A, Beyotime), included: rabbit anti-phospho-ErbB4 (bs-3220R, Bioss; 1:1,000), rabbit anti-ErbB4 (AF6807, Beyotime; 1:1,000), rabbit anti-phospho-Akt1 (AF1546, Beyotime; 1:1,000), mouse anti-Akt1 (sc-377457, Santa Cruz Biotech; 1:1,000), rabbit anti-Nrf2 (AF7623, Beyotime; 1:1,000), rabbit anti-TFRC (AF8136, Beyotime; 1:1,000), rabbit anti-SLC7A11 (GB115276, Servicebio Biotech; 1:1,000), rabbit anti-GPX4 (AF7020, Beyotime; 1:1,000), rabbit anti-Lamin B1 (12987-1-AP, Proteintech, 1:5,000), rabbit anti-p53 (AF5258, Beyotime; 1:1,000), mouse anti-p21 (AP021, Beyotime; 1:1,000), rabbit anti-p16 (bs-23797R, Bioss Biotech, Beijing, China; 1:1,000), and rabbit anti-GAPDH (GB15002, Servicebio Biotech; 1:2000).

    Techniques: Activation Assay, Inhibition, Expressing, Marker

    A NPM1 structural features, including the secondary structure calculated from the oligomerization domain (OD) PDB 4N8M and the nucleic acid binding domain (NBD) PDB 2LLH , using DSSP (2 o Struc.; β-strands are indicated with arrows and α-helicies are indicated with cylinders). The CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.) are shown for the IDR. B p14 ARF structural features, including PSI-PRED secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR), and linear hydropathy (Hydro.). The amino acid sequence conservation (Cons.) is based on a multiple sequence alignment using MUSCLE. The bottom panel shows the Rosetta steric zipper propensity energy (R. Energy) calculated using ZipperDB. C CV-SANS curves for p14 ARF -NPM1 condensates, in 100% D 2 O buffer for full scattering intensity (NPM1 and p14 ARF detected; gray trace), in 45% D 2 O buffer where p14 ARF is contrast matched ([ 2 H]-NPM1 detected; green trace), and in 85% D 2 O buffer where [ 2 H]-NPM1 is contrast matched (p14 ARF detected; blue trace). Correlation peaks at ~200 Å and ~400 Å correspond to meso-scale organization of p14 ARF . All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. D Schematic describing NPM1 with extended IDR conformations. E Schematic describing the spatial organization of p14 ARF within p14 ARF -NPM1 condensates. F 2D CC-DARR spectrum of [ 13 C, 15 N]-p14 ARF within the condensed phase. Select resonance assignments are labeled. G Secondary 13 C chemical shifts for [ 13 C, 15 N]-p14 ARF within the condensed phase. Assigned residues are highlighted in gray. The secondary structure prediction from panel B is shown for reference (2 o Struc.; top).

    Journal: Nature Communications

    Article Title: p14 ARF forms meso-scale assemblies upon phase separation with NPM1

    doi: 10.1038/s41467-024-53904-z

    Figure Lengend Snippet: A NPM1 structural features, including the secondary structure calculated from the oligomerization domain (OD) PDB 4N8M and the nucleic acid binding domain (NBD) PDB 2LLH , using DSSP (2 o Struc.; β-strands are indicated with arrows and α-helicies are indicated with cylinders). The CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.) are shown for the IDR. B p14 ARF structural features, including PSI-PRED secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR), and linear hydropathy (Hydro.). The amino acid sequence conservation (Cons.) is based on a multiple sequence alignment using MUSCLE. The bottom panel shows the Rosetta steric zipper propensity energy (R. Energy) calculated using ZipperDB. C CV-SANS curves for p14 ARF -NPM1 condensates, in 100% D 2 O buffer for full scattering intensity (NPM1 and p14 ARF detected; gray trace), in 45% D 2 O buffer where p14 ARF is contrast matched ([ 2 H]-NPM1 detected; green trace), and in 85% D 2 O buffer where [ 2 H]-NPM1 is contrast matched (p14 ARF detected; blue trace). Correlation peaks at ~200 Å and ~400 Å correspond to meso-scale organization of p14 ARF . All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. D Schematic describing NPM1 with extended IDR conformations. E Schematic describing the spatial organization of p14 ARF within p14 ARF -NPM1 condensates. F 2D CC-DARR spectrum of [ 13 C, 15 N]-p14 ARF within the condensed phase. Select resonance assignments are labeled. G Secondary 13 C chemical shifts for [ 13 C, 15 N]-p14 ARF within the condensed phase. Assigned residues are highlighted in gray. The secondary structure prediction from panel B is shown for reference (2 o Struc.; top).

    Article Snippet: The primary antibodies were used as follows: rabbit monoclonal anti-Cyclophilin B (Cell Signaling, 43603) at 1:1500–1:2000 dilution; rabbit monoclonal anti-GAPDH (Cell Signaling, 5174) at 1:2500 dilution; mouse monoclonal anti-NPM1 (ThermoFisher Scientific, 32-5200) at 1:1000 dillution; mouse monoclonal anti-p14 Arf (Cell Signaling, 2407) at 1:1000–1:15000 dilution; mouse monoclonal anti-GAPDH (Santa Cruz, sc-47724) at 1:2500 dilution; and rabbit polyclonal anti-p14 Arf (Novus, NB200-111) at 1:2000 dilution.

    Techniques: Binding Assay, Cider Assay, Residue, Sequencing, Derivative Assay, Labeling

    A A CC-DARR spectrum acquired for [ 13 C, 15 N]-p14 ARF with 20 ms DARR mixing time shows resonances for T8 in two states, including in an expanded p14 ARF conformation (top), and in a collapsed p14 ARF conformation (bottom). B A CC-DARR spectrum acquired with 400 ms DARR mixing time shows additional cross-peaks indicating intramolecular contacts between T8 and H26. C The 2D-NHHC spectrum (gray) of p14 ARF (equal mixture of [ 13 C]-p14 ARF and [ 15 N]-p14 ARF ) shows that sidechains within the p14 ARF N-terminus make intermolecular contacts within the condensed phase with NPM1. HNCA (magenta) and 2D-HNCACX (blue) spectra for [ 13 C, 15 N]-p14 ARF are shown for reference. D Schematic describing possible modes of p14 ARF intra- and intermolecular interaction.

    Journal: Nature Communications

    Article Title: p14 ARF forms meso-scale assemblies upon phase separation with NPM1

    doi: 10.1038/s41467-024-53904-z

    Figure Lengend Snippet: A A CC-DARR spectrum acquired for [ 13 C, 15 N]-p14 ARF with 20 ms DARR mixing time shows resonances for T8 in two states, including in an expanded p14 ARF conformation (top), and in a collapsed p14 ARF conformation (bottom). B A CC-DARR spectrum acquired with 400 ms DARR mixing time shows additional cross-peaks indicating intramolecular contacts between T8 and H26. C The 2D-NHHC spectrum (gray) of p14 ARF (equal mixture of [ 13 C]-p14 ARF and [ 15 N]-p14 ARF ) shows that sidechains within the p14 ARF N-terminus make intermolecular contacts within the condensed phase with NPM1. HNCA (magenta) and 2D-HNCACX (blue) spectra for [ 13 C, 15 N]-p14 ARF are shown for reference. D Schematic describing possible modes of p14 ARF intra- and intermolecular interaction.

    Article Snippet: The primary antibodies were used as follows: rabbit monoclonal anti-Cyclophilin B (Cell Signaling, 43603) at 1:1500–1:2000 dilution; rabbit monoclonal anti-GAPDH (Cell Signaling, 5174) at 1:2500 dilution; mouse monoclonal anti-NPM1 (ThermoFisher Scientific, 32-5200) at 1:1000 dillution; mouse monoclonal anti-p14 Arf (Cell Signaling, 2407) at 1:1000–1:15000 dilution; mouse monoclonal anti-GAPDH (Santa Cruz, sc-47724) at 1:2500 dilution; and rabbit polyclonal anti-p14 Arf (Novus, NB200-111) at 1:2000 dilution.

    Techniques:

    A The 2D 1 H- 15 N TROSY-HSQC spectrum of [ 13 C, 15 N]-NPM1 within the p14 ARF -NPM1 condensed phase displays resonances from the NPM1 IDR. B Linear net charge per residue (LNCPR) for the NPM1 IDR. Nuclear spin relaxation for [ 2 H, 15 N]-NPM1 in solution (blue scatter points) and condensed phase [ 13 C, 15 N]-NPM1 (red scatter points), including C 1 H- 15 N heteronuclear NOEs, D R 1 , and E R 2 transverse relaxation, which shows a restriction of NPM1 IDR backbone motions on the ps-ns timescale. The error bars for R 1 and R 2 transverse relaxation plots represent the standard errors from curve fitting, as described in Methods. F The contributions from exchange broadening, R ex . G 15 N-CPMG relaxation dispersion profiles for condensed [ 13 C, 15 N]-NPM1 measured at 800 MHz, including A186, T199, and A201, fit to a two-state model. Scatter points represent the decay rates, and the error bars represent the estimated systematic error, as described in Methods. H Schematic describing NPM1 IDR conformational exchange within condensates with p14 ARF .

    Journal: Nature Communications

    Article Title: p14 ARF forms meso-scale assemblies upon phase separation with NPM1

    doi: 10.1038/s41467-024-53904-z

    Figure Lengend Snippet: A The 2D 1 H- 15 N TROSY-HSQC spectrum of [ 13 C, 15 N]-NPM1 within the p14 ARF -NPM1 condensed phase displays resonances from the NPM1 IDR. B Linear net charge per residue (LNCPR) for the NPM1 IDR. Nuclear spin relaxation for [ 2 H, 15 N]-NPM1 in solution (blue scatter points) and condensed phase [ 13 C, 15 N]-NPM1 (red scatter points), including C 1 H- 15 N heteronuclear NOEs, D R 1 , and E R 2 transverse relaxation, which shows a restriction of NPM1 IDR backbone motions on the ps-ns timescale. The error bars for R 1 and R 2 transverse relaxation plots represent the standard errors from curve fitting, as described in Methods. F The contributions from exchange broadening, R ex . G 15 N-CPMG relaxation dispersion profiles for condensed [ 13 C, 15 N]-NPM1 measured at 800 MHz, including A186, T199, and A201, fit to a two-state model. Scatter points represent the decay rates, and the error bars represent the estimated systematic error, as described in Methods. H Schematic describing NPM1 IDR conformational exchange within condensates with p14 ARF .

    Article Snippet: The primary antibodies were used as follows: rabbit monoclonal anti-Cyclophilin B (Cell Signaling, 43603) at 1:1500–1:2000 dilution; rabbit monoclonal anti-GAPDH (Cell Signaling, 5174) at 1:2500 dilution; mouse monoclonal anti-NPM1 (ThermoFisher Scientific, 32-5200) at 1:1000 dillution; mouse monoclonal anti-p14 Arf (Cell Signaling, 2407) at 1:1000–1:15000 dilution; mouse monoclonal anti-GAPDH (Santa Cruz, sc-47724) at 1:2500 dilution; and rabbit polyclonal anti-p14 Arf (Novus, NB200-111) at 1:2000 dilution.

    Techniques: Residue, Dispersion

    A p14 ARF structural features, including PSI-PRED4.0 secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.). The CIDER analysis for p14 ARF ΔH1-3 is shown below. B Zoomed in regions from confocal fluorescence micrographs of NPM1-AF488 in condensates with p14 ARF (top) and p14 ARF ΔH1-3 (bottom). Scale bars = 10 µm. C Index of dispersion for NPM1 in condensates with p14 ARF (gray boxes, whiskers and trace; derived from n = 6, 6, 6, 7, 6, 6, 7, 6, 6, 6, 7 images) and p14 ARF ΔH1-3 (blue boxes and whiskers and trace, where n = 5, 4, 6, 6, 8, 6, 6, 6, 6, 6, 6 images). Whiskers extend from the box to the furthest point within 1.5x the inter-quartile range. The black arrow highlights the increased NPM1 saturation concentration, ΔC sat , upon substitution of p14 ARF hydrophobic residues to Gly/Ser spacer residues. The gray arrow highlights the reentrant phase transition, which occurs at elevated p14 ARF concentrations. D ΔG tr for NPM1 in condensates with p14 ARF (gray boxes, whiskers and trace, where n = 696, 42, 61, 159, 225, 285, 333, 276, 306, 227, 773 condensates) and p14 ARF ΔH1-3 (blue boxes, whiskers and trace, where n = 2561, 1787, 29, 31, 82, 92, 134, 153, 166, 145, 162 condensates). Whiskers extend from the box to the furthest point within 1.5x the inter-quartile range. The C sat for NPM1 increases when p14 ARF hydrophobic residues are substituted. The gray arrow highlights the destabilization of NPM1 during the reentrant phase transition. E CV-SANS curves for p14 ARF ΔH1-3-[ 2 H]-NPM1 condensates collected at 50% D 2 O, where p14 ARF ΔH1-3 is contrast matched ([ 2 H]-NPM1 detected; green trace), at 85% D 2 O where [ 2 H]-NPM1 is contrast matched (p14 ARF ΔH1-3 detected; blue trace), and p14 ARF ΔH1-3-NPM1 condensate at 100% D 2 O for full scattering intensity (NPM1 and p14 ARF ΔH1-3 detected; gray trace). All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. F Schematic describing condensed NPM1 with extended IDR conformations. G Schematic describing condensed p14 ARF ΔH1-3 in an extended conformation. H FRAP of NPM1-AF488 within condensates shows that substitution of p14 ARF hydrophobic residues to Gly/Ser spacer residues restores NPM1 mobility. Scale bars = 1 µm. I FRAP recovery curves for p14 ARF -NPM1 and p14 ARF ΔH1-3-NPM1 condensates with fits, as described in Methods (statistical significance was assessed by two-sided Wilcoxon rank-sum test, n = 10 curves for each condition, the p -value is shown in the figure). J NPM1-AF488 D App values extracted from the FRAP recovery curves in panel I (statistical significance was assessed by two-sided Wilcoxon rank-sum test, n = 10 D App values for each condition, the p -value is shown in the figure).

    Journal: Nature Communications

    Article Title: p14 ARF forms meso-scale assemblies upon phase separation with NPM1

    doi: 10.1038/s41467-024-53904-z

    Figure Lengend Snippet: A p14 ARF structural features, including PSI-PRED4.0 secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.). The CIDER analysis for p14 ARF ΔH1-3 is shown below. B Zoomed in regions from confocal fluorescence micrographs of NPM1-AF488 in condensates with p14 ARF (top) and p14 ARF ΔH1-3 (bottom). Scale bars = 10 µm. C Index of dispersion for NPM1 in condensates with p14 ARF (gray boxes, whiskers and trace; derived from n = 6, 6, 6, 7, 6, 6, 7, 6, 6, 6, 7 images) and p14 ARF ΔH1-3 (blue boxes and whiskers and trace, where n = 5, 4, 6, 6, 8, 6, 6, 6, 6, 6, 6 images). Whiskers extend from the box to the furthest point within 1.5x the inter-quartile range. The black arrow highlights the increased NPM1 saturation concentration, ΔC sat , upon substitution of p14 ARF hydrophobic residues to Gly/Ser spacer residues. The gray arrow highlights the reentrant phase transition, which occurs at elevated p14 ARF concentrations. D ΔG tr for NPM1 in condensates with p14 ARF (gray boxes, whiskers and trace, where n = 696, 42, 61, 159, 225, 285, 333, 276, 306, 227, 773 condensates) and p14 ARF ΔH1-3 (blue boxes, whiskers and trace, where n = 2561, 1787, 29, 31, 82, 92, 134, 153, 166, 145, 162 condensates). Whiskers extend from the box to the furthest point within 1.5x the inter-quartile range. The C sat for NPM1 increases when p14 ARF hydrophobic residues are substituted. The gray arrow highlights the destabilization of NPM1 during the reentrant phase transition. E CV-SANS curves for p14 ARF ΔH1-3-[ 2 H]-NPM1 condensates collected at 50% D 2 O, where p14 ARF ΔH1-3 is contrast matched ([ 2 H]-NPM1 detected; green trace), at 85% D 2 O where [ 2 H]-NPM1 is contrast matched (p14 ARF ΔH1-3 detected; blue trace), and p14 ARF ΔH1-3-NPM1 condensate at 100% D 2 O for full scattering intensity (NPM1 and p14 ARF ΔH1-3 detected; gray trace). All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. F Schematic describing condensed NPM1 with extended IDR conformations. G Schematic describing condensed p14 ARF ΔH1-3 in an extended conformation. H FRAP of NPM1-AF488 within condensates shows that substitution of p14 ARF hydrophobic residues to Gly/Ser spacer residues restores NPM1 mobility. Scale bars = 1 µm. I FRAP recovery curves for p14 ARF -NPM1 and p14 ARF ΔH1-3-NPM1 condensates with fits, as described in Methods (statistical significance was assessed by two-sided Wilcoxon rank-sum test, n = 10 curves for each condition, the p -value is shown in the figure). J NPM1-AF488 D App values extracted from the FRAP recovery curves in panel I (statistical significance was assessed by two-sided Wilcoxon rank-sum test, n = 10 D App values for each condition, the p -value is shown in the figure).

    Article Snippet: The primary antibodies were used as follows: rabbit monoclonal anti-Cyclophilin B (Cell Signaling, 43603) at 1:1500–1:2000 dilution; rabbit monoclonal anti-GAPDH (Cell Signaling, 5174) at 1:2500 dilution; mouse monoclonal anti-NPM1 (ThermoFisher Scientific, 32-5200) at 1:1000 dillution; mouse monoclonal anti-p14 Arf (Cell Signaling, 2407) at 1:1000–1:15000 dilution; mouse monoclonal anti-GAPDH (Santa Cruz, sc-47724) at 1:2500 dilution; and rabbit polyclonal anti-p14 Arf (Novus, NB200-111) at 1:2000 dilution.

    Techniques: Cider Assay, Residue, Fluorescence, Dispersion, Derivative Assay, Concentration Assay, Sublimation

    A Zoomed in regions from fluorescence microscopy images of live DLD-1 NPM1-G (clone B11) cells, before and after 48 h of doxycycline induced p14 ARF -iRFP expression. Scale bars = 2 µm. B Z-score analysis of NPM1-GFP and p14 ARF -iRFP levels in DLD-1 NPM1-G cells, showing that p14 ARF and NPM1 levels are anti-correlated (statistical significance was assessed by two-sided Mann–Whitney U-test, n = 2272, 122, 54 cells, p -values are shown in the figure) C FRAP curves with fits, as described in Methods, for cells sorted from the DLD-1 NPM1-G population shown in B. The curves on the left are from a cell expressing a high level of nucleolar NPM1 (clone F6; green trace) and a low level of nucleolar p14 ARF (clone F6; blue trace). The curves on the right are from a cell expressing a low level of nucleolar NPM1 (clone G2; green trace) and a high level of nucleolar p14 ARF (clone G2; blue traces). In unsorted DLD-1 NPM1-G cells, D The D App and E mobility for nucleolar NPM1-GFP and p14 ARF -iRFP (small green and blue transparent markers, respectively, n = 45 cells) are reduced as nucleolar p14 ARF -iRFP levels increase. Reductions also occur as the duration of p14 ARF -iRFP expression is extended (large opaque markers; scatter points represent the mean and error bars represent the standard deviation, where n = 20 cells). F A schematic describing the correlated reductions in p14 ARF and NPM1 dynamics and their assembly into large molecular weight complexes within the granular component (GC) of the nucleolus.

    Journal: Nature Communications

    Article Title: p14 ARF forms meso-scale assemblies upon phase separation with NPM1

    doi: 10.1038/s41467-024-53904-z

    Figure Lengend Snippet: A Zoomed in regions from fluorescence microscopy images of live DLD-1 NPM1-G (clone B11) cells, before and after 48 h of doxycycline induced p14 ARF -iRFP expression. Scale bars = 2 µm. B Z-score analysis of NPM1-GFP and p14 ARF -iRFP levels in DLD-1 NPM1-G cells, showing that p14 ARF and NPM1 levels are anti-correlated (statistical significance was assessed by two-sided Mann–Whitney U-test, n = 2272, 122, 54 cells, p -values are shown in the figure) C FRAP curves with fits, as described in Methods, for cells sorted from the DLD-1 NPM1-G population shown in B. The curves on the left are from a cell expressing a high level of nucleolar NPM1 (clone F6; green trace) and a low level of nucleolar p14 ARF (clone F6; blue trace). The curves on the right are from a cell expressing a low level of nucleolar NPM1 (clone G2; green trace) and a high level of nucleolar p14 ARF (clone G2; blue traces). In unsorted DLD-1 NPM1-G cells, D The D App and E mobility for nucleolar NPM1-GFP and p14 ARF -iRFP (small green and blue transparent markers, respectively, n = 45 cells) are reduced as nucleolar p14 ARF -iRFP levels increase. Reductions also occur as the duration of p14 ARF -iRFP expression is extended (large opaque markers; scatter points represent the mean and error bars represent the standard deviation, where n = 20 cells). F A schematic describing the correlated reductions in p14 ARF and NPM1 dynamics and their assembly into large molecular weight complexes within the granular component (GC) of the nucleolus.

    Article Snippet: The primary antibodies were used as follows: rabbit monoclonal anti-Cyclophilin B (Cell Signaling, 43603) at 1:1500–1:2000 dilution; rabbit monoclonal anti-GAPDH (Cell Signaling, 5174) at 1:2500 dilution; mouse monoclonal anti-NPM1 (ThermoFisher Scientific, 32-5200) at 1:1000 dillution; mouse monoclonal anti-p14 Arf (Cell Signaling, 2407) at 1:1000–1:15000 dilution; mouse monoclonal anti-GAPDH (Santa Cruz, sc-47724) at 1:2500 dilution; and rabbit polyclonal anti-p14 Arf (Novus, NB200-111) at 1:2000 dilution.

    Techniques: Fluorescence, Microscopy, Expressing, MANN-WHITNEY, Standard Deviation, Molecular Weight